On January 30, 2024, Aqemia SAS closed the transaction. The company has received ?30 million in its second and final tranche closing led by new investor Wendel Growth and received a total of ?60 million in the transaction. The company issued common shares in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.6 EUR | +0.71% | +0.12% | +19.14% |
May. 10 | Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director | CI |
May. 07 | Zest discloses exit from startup Futura; return investment 15 times | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.14% | 6.79B | |
-1.86% | 118B | |
+3.26% | 95.3B | |
+13.75% | 69.05B | |
+20.25% | 63.76B | |
+12.28% | 43.7B | |
+14.14% | 43.06B | |
+17.76% | 34.41B | |
+3.63% | 24.92B | |
-1.14% | 23.07B |
- Stock Market
- Equities
- RF Stock
- News Eurazeo SE
- Aqemia SAS announced that it has received ?60 million in funding from Bpifrance Investissement SAS, Eurazeo SE, Elaia Partners, Wendel Growth